Publications

Export 11 results:
Author Title [ Type(Asc)] Year
Filters: Author is Lam, Raymond W  [Clear All Filters]
Journal Article
McGirr A, Berlim M, Bond DJ, Neufeld NH, Chan PY, Yatham LN, Lam RW.  2015.  A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability.. J Psychiatr Res. 62:23-30.
Bhat V, Leong K, Lee J, Voineskos D, Daskalakis ZJ, Lam RW, Jollant F.  2014.  Research-track programs for residents in psychiatry: a review of literature and a report of 3 Canadian experiences.. Can J Psychiatry. 59(5):268-75.
Wang JL, Lam RW, Ho K, Attridge M, Lashewicz BM, Patten SB, Marchand A, Aiken A, Schmitz N, Gundu S et al..  2016.  Preferred Features of E-Mental Health Programs for Prevention of Major Depression in Male Workers: Results From a Canadian National Survey.. J Med Internet Res. 18(6):e132.
Belzeaux R, Fiori LM, Lopez JPablo, Boucekine M, Boyer L, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW et al..  2019.  Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment.. J Clin Psychiatry. 80(3)
Lopez JPablo, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, Heller EA, Vialou V, Ku SM, Gerald C et al..  2017.  MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.. Nat Commun. 8:15497.
Wang JL, Patten SB, Lam RW, Attridge M, Ho K, Schmitz N, Marchand A, Lashewicz BM.  2016.  The Effects of an E-Mental Health Program and Job Coaching on the Risk of Major Depression and Productivity in Canadian Male Workers: Protocol for a Randomized Controlled Trial.. JMIR Res Protoc. 5(4):e218.
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR et al..  2016.  Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.. BMC Psychiatry. 16:105.
Desan PH, Weinstein AJ, Michalak EE, Tam EM, Meesters Y, Ruiter MJ, Horn E, Telner J, Iskandar H, Boivin DB et al..  2007.  A controlled trial of the Litebook light-emitting diode (LED) light therapy device for treatment of Seasonal Affective Disorder (SAD).. BMC Psychiatry. 7:38.
Baskaran A, Farzan F, Milev R, Brenner CA, Alturi S, McAndrews MPat, Blier P, Evans K, Foster JA, Frey BN et al..  2017.  The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study.. J Affect Disord. 227:542-549.
Kennedy SH, Lam RW, McIntyre RS, S Tourjman V, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, Macqueen GM et al..  2016.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.. Can J Psychiatry. 61(9):540-60.
McGirr A, Berlim M, Bond DJ, Chan PY, Yatham LN, Lam RW.  2017.  Adjunctive ketamine in electroconvulsive therapy: updated systematic review and meta-analysis.. Br J Psychiatry. 210(6):403-407.

  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre